HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
Department of Health and Human Services
This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program. The scope will therefore be focused on development of assays to support a distinct testing funnel, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents (including small molecules, biologics, and natural products).
Funding
Award size
$100K – $1M
Award ceiling
350000
Type
Grant
Dates
Deadline
Later
Posted
09/18/2024
Closes
2027-01-15
Eligibility
Eligibility
Native American tribal governments (Federally recognized)Others (see text field entitled "Additional Information on Eligibility" for clarification)Small businessesSpecial district governmentsFor profit organizations other than small businessesIndependent school districtsPublic housing authorities/Indian housing authoritiesCounty governmentsPublic and State controlled institutions of higher educationNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationState governmentsCity or township governments
Program
Funding area
Education - EDFood and Nutrition - FNHealth - HLIncome Security and Social Services - ISS
Opportunity #
RFA-NS-25-023
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov